Evidence map›Paper›PMID 30937369›Full record

ArticleACS central science2019

3D Printed Absorber for Capturing Chemotherapy Drugs before They Spread through the Body.

Hee Jeung Oh, Mariam S Aboian, Michael Y J Yi, Jacqueline A Maslyn, Whitney S Loo, Xi Jiang, Dilworth Y Parkinson, Mark W Wilson, Terilyn Moore, Colin R Yee and 5 more

Open access · diamondAbstract read
In one paragraph

Article in ACS central science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Carboxyl Dissociation Degree (Macromolecules · 2026
    Article
  3. 3D Printed Biosponge Adsorbers for Capturing Toxic Chemotherapy DrugsACS biomaterials science & engineering · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Scalable 3D-printed lattices for pressure control in fluid applications.AIChE journal. American Institute of Chemical Engineers · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Hee Jeung OhDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, California 94720, United States.
Mariam S AboianDepartment of Radiology, School of Medicine, University of California, San Francisco, California 94110, United States.
Michael Y J YiDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, California 94720, United States.
Jacqueline A MaslynDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, California 94720, United States.
Whitney S LooDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, California 94720, United States.
Xi JiangEnergy Storage and Distributed Resources Division, Joint Center for Energy Storage Research (JCESR), Materials Sciences Division, Advanced Light Source Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
Dilworth Y ParkinsonEnergy Storage and Distributed Resources Division, Joint Center for Energy Storage Research (JCESR), Materials Sciences Division, Advanced Light Source Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States.
Mark W WilsonDepartment of Radiology, School of Medicine, University of California, San Francisco, California 94110, United States.
Terilyn MooreDepartment of Radiology, School of Medicine, University of California, San Francisco, California 94110, United States.
Colin R YeeDepartment of Radiology, School of Medicine, University of California, San Francisco, California 94110, United States.
Gregory R RobbinsCarbon, Inc., 1089 Mills Way, Redwood City, California 94063, United States.
Florian M BarthCarbon, Inc., 1089 Mills Way, Redwood City, California 94063, United States.
Joseph M DeSimoneCarbon, Inc., 1089 Mills Way, Redwood City, California 94063, United States.
Steven W HettsDepartment of Radiology, School of Medicine, University of California, San Francisco, California 94110, United States.
Nitash P BalsaraDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, California 94720, United States.
University of California, San Francisco · USUniversity of California, Berkeley · USLawrence Berkeley National Laboratory · USCarbon180 · USUniversity of North Carolina at Chapel Hill · US

Funding

Resource for Biocomputing Visualization and InformaticsP41GM103311 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2012 to 2017
$8.2M
Biomedical Imaging for Clinician ScientistsT32EB001631 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI THOMAS M LINK · 2005 to 2026
$5.6M
Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce ToxicityR01CA194533 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HETTS, STEVEN WILLIAM · 2015 to 2019
$2.6M
NCI NIH HHS R01 CA194533NIBIB NIH HHS T32 EB001631NIGMS NIH HHS P41 GM103311
6 · The paper itself

Abstract

Despite efforts to develop increasingly targeted and personalized cancer therapeutics, dosing of drugs in cancer chemotherapy is limited by systemic toxic side effects. We have designed, built, and deployed porous absorbers for capturing chemotherapy drugs from the bloodstream after these drugs have had their effect on a tumor, but before they are released into the body where they can cause hazardous side effects. The support structure of the absorbers was built using 3D printing technology. This structure was coated with a nanostructured block copolymer with outer blocks that anchor the polymer chains to the 3D printed support structure and a middle block that has an affinity for the drug. The middle block is polystyrenesulfonate which binds to doxorubicin, a widely used and effective chemotherapy drug with significant toxic side effects. The absorbers are designed for deployment during chemotherapy using minimally invasive image-guided endovascular surgical procedures. We show that the introduction of the absorbers into the blood of swine models enables the capture of 64 ± 6% of the administered drug (doxorubicin) without any immediate adverse effects. Problems related to blood clots, vein wall dissection, and other biocompatibility issues were not observed. This development represents a significant step forward in minimizing toxic side effects of chemotherapy.

Identifiers

PMID30937369
PMCPMC6439445
OpenAlexW2910404825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.